November 21, 2022
Pain is how our bodies tell us something’s wrong, alerting us to injury or infection and helping doctors make a diagnosis. But pain is not fun, […]
November 17, 2022
WASHINGTON, DC — For patients with acute-on-chronic liver failure (ACLF) undergoing modest-volume paracentesis for ascites, oral midodrine may be an alternative to intravenous albumin for preventing […]
November 15, 2022
VIENNA ― Experts in Maastricht, the Netherlands, have updated the 2017 Helicobacter pylori consensus report, now referred to as the Maastricht VI/Florence Consensus Report. Published in […]
November 12, 2022
Untreated chronic hepatitis B infections are associated with increased risks of most major extrahepatic cancer types, shows a new study conducted in South Korea. In this […]
November 12, 2022
Living donor liver transplants (LDLT) for recipients with the most urgent need for a liver transplant in the next 3 months – a model for end-stage […]
November 11, 2022
US mortality for alcohol-associated liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) increased at “alarming” rates during the COVID-19 pandemic, according to new findings presented at […]
November 9, 2022
WASHINGTON — Adding granulocyte-colony stimulating factor (G-CSF) to steroid therapy can improve 90-day survival for patients with severe alcoholic hepatitis (SAH), researchers from India reported. Among […]
November 9, 2022
Nearly three-quarters of Americans would wait before discussing GI symptoms with a health care provider if their bowel frequency or symptoms changed, with more than a […]
November 9, 2022
Among people with nonalcoholic fatty liver disease (NAFLD), the fibrosis progression rate was higher among those who also had diabetes, according to new findings presented at the annual […]